Release Date: 30/07/12 17:03 Summary: Quarterly Activities and Cashflow Report Price Sensitive: Yes Download Document 329.46KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%